Adagio Therapeutics shares jumped 22% in premarket trading

144
10
Favorite

Adagio Therapeutics shares jumped 22% in premarket trading

Tiger Newspress2022-01-13

Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.Adagio Therapeutics summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron (B.1.1.529) variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

144

Report

Comment（10）

BKT
·2022-01-14
Good. Pls like thanks.
Reply
1
Report
来人
·2022-01-13
Nice
Reply
2
Report
Botak Tur
·2022-01-13
Ok
Reply
3
Report
vttoh
·2022-01-13
Okay
Reply
3
Report
koolgal
·2022-01-13
Any vaccine or drug to do with Omicron gets star rating and Adagio Therapeutics is the latest company to show promising results for their drug. 22% up in premarket shows investors are keen to be part of it!🚀🚀🚀🌙🌙🌙
Reply
11
Report
MuppyKoh
·2022-01-13
Please like
Reply
6
Report
MuppyKoh
·2022-01-13
Please like
Reply
7
Report
Tedam
·2022-01-13
Pls like
Reply
7
Report
JayWin
·2022-01-13
Please reply and like, thanks
Reply
6
Report
Bingbong
·2022-01-13
Okay, whatever..
Reply
7
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1155797604?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-13 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155797604","market":"us","top_or_hot":-1,"title":"Adagio Therapeutics shares jumped 22% in premarket trading","media":"Tiger Newspress","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/ADGI\">Adagio Therapeutics</a> shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.<img src=\"https://static.tigerbbs.com/835a5e8d01f56d120170cb4189fb383f\" tg-width=\"1026\" tg-height=\"634\" width=\"100%\" height=\"auto\"/>Adagio Therapeutics summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron (B.1.1.529) variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adagio Therapeutics shares jumped 22% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdagio Therapeutics shares jumped 22% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n2022-01-13 17:44 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.Adagio Therapeutics summarized recent findings ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1155797604","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155797604","pubTimestamp":1642067062,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"柔板治疗公司的股票在盘前交易中上涨了22%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADGI":0.9},"content_text":"Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.Adagio Therapeutics summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron (B.1.1.529) variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9002716625,"gmtCreate":1642091166543,"gmtModify":1676533680271,"author":{"id":"3570853427202414","authorId":"3570853427202414","name":"BKT","avatar":"https://community-static.tradeup.com/news/15cb8e8f0a7c44ca01c83b3bfdddbd86","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3570853427202414","authorIdStr":"3570853427202414"},"htmlText":"Good. Pls like thanks.","listText":"Good. Pls like thanks.","text":"Good. Pls like thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002716625","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002422268,"gmtCreate":1642077283075,"gmtModify":1676533678377,"author":{"id":"3575544575320394","authorId":"3575544575320394","name":"来人","avatar":"https://static.tigerbbs.com/0af89587decbb8a1d3e1596adc29cb98","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3575544575320394","authorIdStr":"3575544575320394"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002422268","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002469924,"gmtCreate":1642071644486,"gmtModify":1676533677932,"author":{"id":"3578990746736424","authorId":"3578990746736424","name":"Botak Tur","avatar":"https://static.tigerbbs.com/ad2db38166c18b512749a83019596279","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3578990746736424","authorIdStr":"3578990746736424"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002469924","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002486872,"gmtCreate":1642069998236,"gmtModify":1676533677814,"author":{"id":"4101538323380760","authorId":"4101538323380760","name":"vttoh","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4101538323380760","authorIdStr":"4101538323380760"},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002486872","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002481117,"gmtCreate":1642069315688,"gmtModify":1676533677782,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"htmlText":"Any vaccine or drug to do with Omicron gets star rating and Adagio Therapeutics is the latest company to show promising results for their drug.&nbsp; 22% up in premarket shows investors are keen to be part of it!🚀🚀🚀🌙🌙🌙","listText":"Any vaccine or drug to do with Omicron gets star rating and Adagio Therapeutics is the latest company to show promising results for their drug.&nbsp; 22% up in premarket shows investors are keen to be part of it!🚀🚀🚀🌙🌙🌙","text":"Any vaccine or drug to do with Omicron gets star rating and Adagio Therapeutics is the latest company to show promising results for their drug. 22% up in premarket shows investors are keen to be part of it!🚀🚀🚀🌙🌙🌙","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002481117","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002417986,"gmtCreate":1642068074257,"gmtModify":1676533677635,"author":{"id":"3585354270249282","authorId":"3585354270249282","name":"MuppyKoh","avatar":"https://static.tigerbbs.com/280b63f52e5976fb134c31bfb22ec07d","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3585354270249282","authorIdStr":"3585354270249282"},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002417986","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002417016,"gmtCreate":1642068060830,"gmtModify":1676533677636,"author":{"id":"3585354270249282","authorId":"3585354270249282","name":"MuppyKoh","avatar":"https://static.tigerbbs.com/280b63f52e5976fb134c31bfb22ec07d","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3585354270249282","authorIdStr":"3585354270249282"},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002417016","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002415460,"gmtCreate":1642067709418,"gmtModify":1676533677604,"author":{"id":"3574663138666653","authorId":"3574663138666653","name":"Tedam","avatar":"https://static.tigerbbs.com/b03558df0abaa80f9e6b141bb1e3d38e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574663138666653","authorIdStr":"3574663138666653"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002415460","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002415562,"gmtCreate":1642067699490,"gmtModify":1676533677604,"author":{"id":"3581832598723204","authorId":"3581832598723204","name":"JayWin","avatar":"https://static.tigerbbs.com/e7fe632cbb77a4bc57ba97f59aeb8162","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581832598723204","authorIdStr":"3581832598723204"},"htmlText":"Please reply and like, thanks&nbsp;","listText":"Please reply and like, thanks&nbsp;","text":"Please reply and like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002415562","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9002415063,"gmtCreate":1642067538254,"gmtModify":1676533677596,"author":{"id":"3584491863458709","authorId":"3584491863458709","name":"Bingbong","avatar":"https://static.tigerbbs.com/526d3fc1904d3524a8728aaf6cad6aed","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":1,"idStr":"3584491863458709","authorIdStr":"3584491863458709"},"htmlText":"Okay, whatever..","listText":"Okay, whatever..","text":"Okay, whatever..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002415063","repostId":1155797604,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":144,"commentSize":10,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}